Sponsor:
NYU Langone Health
Code:
NCT05807048
Conditions
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Daratumumab and Hyaluronidase-fihj
Pre-Intervention Medication
Post-Intervention Medication
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2025-03-12.